Rollins, Inc. (ROL) — Fair Value Analysis

Base-case fair value (P50): $46.25 · Current price: $53.42 · Verdict: Fairly Valued

The Verdict on ROL

Rollins, Inc. (ROL) appears overvalued based on our latest Monte Carlo simulations. Our analysis indicates a median fair value (P50) of $46.54, significantly below its current trading price of $53.74. This suggests an implied downside of -13.4% from current levels. The simulations, which model thousands of forward scenarios, consistently point to ROL trading above its intrinsic value. Investors considering ROL at its current price should be aware of this notable discrepancy, suggesting limited upside potential and a higher risk profile according to our quantitative framework. This valuation verdict is a critical consideration for those evaluating new positions or existing holdings in the Consumer Cyclical sector.

How ROL stacks up against Consumer Cyclical

While Rollins, Inc. operates within the Consumer Cyclical sector, its current valuation diverges from what our models suggest. The company's quality tier, assessed across operational and financial health metrics relative to its industry peers, is categorized as average. Despite this average fundamental health, ROL trades at $53.74, implying a premium when its median fair value is calculated at $46.54. This -13.4% discrepancy between the current price and the P50 fair value is particularly salient for a company with an average quality rating in a sector often characterized by cyclical sensitivities. The market appears to be assigning a valuation above its quantitatively derived intrinsic worth, even with a foundational quality that isn't exceptional within its competitive landscape.

What this means for investors

For investors, the present analysis suggests caution when evaluating Rollins, Inc. at its $53.74 current price. The consistent finding from our Monte Carlo simulations, indicating a median fair value (P50) of $46.54 and a -13.4% overvaluation, underscores a challenging risk/reward profile. Even with an average quality tier, the market price commands a premium not supported by our quantitative models. While a downside scenario is implied by the current valuation, the full spectrum of potential outcomes, including the specific targets for bull and bear cases, provides a more comprehensive view. Unlock the complete Monte Carlo distribution, including the P10 and P90 targets and track ROL's fair value as new fundamentals are released by signing up for a free FairCurve account.